Eléments de l'association

	Bavière	120
	Hendrik Schulze-Koops	8
	Bavière *Sauf* Hendrik Schulze-Koops"	116
	Hendrik Schulze-Koops *Sauf* Bavière"	4
	Bavière Et Hendrik Schulze-Koops	4
	Bavière Ou Hendrik Schulze-Koops	124
	*Corpus*	6869

List of bibliographic references

Number of relevant bibliographic references: 4.

Ident.	Authors (with country if any)	Title
000626	Claudia Dechant [Allemagne] ; Hendrik Schulze-Koops [Allemagne]	[Update Giant Cell Arteriitis].
001229	Michael Czihal [Allemagne] ; Christian Lottspeich [Allemagne] ; Angelika Schröttle [Allemagne] ; Karla Maria Treitl [Allemagne] ; Marcus Treitl [Allemagne] ; Jan Leipe [Allemagne] ; Hendrik Schulze-Koops [Allemagne] ; Ulrich Hoffmann [Allemagne] ; Claudia Dechant [Allemagne]	Relapses in three patients with Takayasu arteritis under tocilizumab treatment detected by contrast enhanced ultrasound.
001840	Christopher J. Edwards [Royaume-Uni] ; Bruno Fautrel [France] ; Hendrik Schulze-Koops [Allemagne] ; Tom W J. Huizinga [Pays-Bas] ; Klaus Kruger [Allemagne]	Dosing down with biologic therapies: a systematic review and clinicians’ perspective
004424	Thomas Dörner [Allemagne] ; Hendrik Schulze-Koops [Allemagne] ; Gerd-Rüdiger Burmester [Allemagne] ; Christof Iking-Konert [Allemagne] ; Marc Schmalzing [Allemagne] ; Andreas Engel [Allemagne] ; Peter K Stner [Allemagne] ; Herbert Kellner [Allemagne] ; Reiner Kurthen [Allemagne] ; Klaus Krüger [Allemagne] ; Andrea Rubbert-Roth [Allemagne] ; Holger Schwenke [Allemagne] ; Marvin A. Peters [Allemagne] ; Hans-Peter Tony [Allemagne]	Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI).

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021